MUC1-CEA-ERBB2-telomerase-BIRC5-MAGEA1-RNA-vaccine (CureVac)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMUC1-CEA-ERBB2-telomerase-BIRC5-MAGEA1-RNA-vaccine (CureVac)

Drug Alias NameRNAactive renal cell carcinoma vaccine - CureVacmRNA renal cell carcinoma vaccine - CureVacRNAactive RCC vaccine - CureVacmRNA RCC vaccine - CureVacTAA mRNA vaccine - CureVac +[6]

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCurevac Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCurevac Ag

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A